INTRODUCTION
The increased incidence of clinical and chemical diabetes in Friedreich's Ataxia has been described in this (Shapcott et al., 1976 , Draper et al., 1979 and other laboratories. While a number of patients are insulin dependent diabetics, there is also a significant fraction of borderline cases, where a mild glucose intolerance or chemical diabetes is present. A hyperinsulinemic response to the oral glucose tolerance test (OGTT) is also noted in many Friedreich's ataxia patients. It was suggested that the observed glucose intolerance, especially in the borderline cases, could be due in part to the low muscle mass, and hence, abnormal glucose utilization.
With the recent development of more rapid chromatographic assays for glycosylated or "fast" hemoglobins, this approach is gaining acceptance as an additional method for assessing the degree of control of hyperglycemia in diabetic patients. We have therefore measured glycosylated hemoglobin levels in Friedreich's Ataxia patients and in family members to determine the extent of sustained hyperglycemia in these subjects, and thus further defining the diabetic status in Friedreich's Ataxia. 
SUBJECTS AND METHODS
Typical Friedreich's ataxia (Group I a) patients (Shapcott et al., 1976) and family members (heterozygotes and siblings*) were studied. Non-diabetic control subjects were apparently healthy adult volunteers from laboratory and secretarial personnel, while diabetic controls were poorly controlled adult diabetics being monitored in the Diabetes Clinic, CHUS.
Blood samples for glycosylated hemoglobin determinations were collected in tubes containing EDTA, THE CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES while samples for plasma glucose were collected in tubes containing oxalate. Plasma glucose was determined by the o-tuluidine method. Glycosylated hemoglobins were determined by two methods: 1) Total fast hemoglobin (HbA, a +b+ c ) was estimated using the Helena Glycosylated Hemoglobin Quik Column Kit (Helena Laboratories, Beaumont, Texas). 2) Hemoglobins HbA, a +b and HbA lc were determined using the micro chromatographic method of Jones et al. (1978) . The results of these determinations are expressed as the percentage of the total hemoglobin.
•Siblings: possible heterozygotes and normal Table I shows the mean percentage of glycosylated hemoglobins in the various groups, as determined by the two methods, along with the plasma glucose. The distribution of the total fast hemoglobins (method 1) for each of the subject groups is illustrated graphically in Fig. 1 .
RESULTS
While the mean glycosylated hemoglobin levels for the Friedreich's Ataxia group as a whole were not greatly above those for non-diabetic control subjects, 3 insulin dependent diabetics showed elevated plasma glucose and glycosylated hemoglobin concentrations. Total fast hemoglobin along with HbA, a +b and HbA, c levels for the remaining Friedreich's ataxia patients were not significantly different from those of non-diabetic controls. The total fast hemoglobin as determined by method 1 in the heterozygotes was slightly higher than that for the controls (p<0.02), however, the HbA,a+b and HbA, c as determined by method 2 were not significantly higher. The apparent difference between the two methods may be in part due to the fact that only four subjects were submitted to both analytical methods.
DISCUSSION
Following the observation of a large proportion of borderline oral glucose tolerance tests in Friedreich's ataxia patients, and in view of the possible ambiguity in interpretation of these results, an alternative method for detection of a sustained hyperglycemia in these patients is desirable. Determination of glycosylated or "fast" hemoglobins represents an attractive approach especially with the recent introduction of rapid chromatographic assays.
At least four fast hemoglobins are known (Dods and Bolmey, 1979) : of these HbA K is the major component and has been the most widely studied. HbA, c has been shown to be formed by a slow, essentially irreversible reaction of the major hemoglobin HbAn with glucose throughout the lifetime of the red cell (Gonen and Rubenstein, 1978) . Thus, the HbA, c level represents a time averaged glucose concentration over the life of the red cell, and as a consequence, levels in poorly controlled diabetics are approximately twice the normal values. Furthermore, levels decrease to near normal over a period of several weeks after initiation of control of hyperglycemia. Although there is now some controversy over the effects of short-term variations in blood glucose on glycosylated hemoglobin levels (Brooks et al., 1979 , Leslie et al., 1979 this method has gained acceptance as an approach to the evaluation of the degree of control of hyperglycemia without the wide variation possible from single glucose determinations.
The HbA, c fraction is increased the most in poorly controlled diabetic patients, therefore we determined HbA, c levels as well as the total glycosylated hemoglobins, since there existed the possibility that changes in HbA |c could be masked in the total fast hemoglobin determination. However, the minor glycosylated hemoglobins also increase in diabetes, and we found that the much faster and easier total glycosylated hemoglobin determination using the commercially available kits gave results which parallel those for HbA, c (Table 1) .
The greatly increased glycosylated hemoglobins in the insulin dependent diabetic Friedreich's Ataxia patients are consistent with the increased blood glucose in these subjects (Table 1) . Williams and Savage (1979) 
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Glycosylated Hemoglobins in Friedrich's Ataxia objective monitor of blood glucose control in children with diabetes mellitus than other commonly used methods, and therefore measurement of fast hemoglobin levels could be recommended in assessing the long term control of diabetes in Friedreich's Ataxia patients. The non-diabetic Friedreich's Ataxia patients do not show a significant increase in fast hemoglobin, in spite of the abnormal GTT and the abnormal insulin response to the GTT shown by a number of these patients. We therefore conclude that any sustained hyperglycemia in this group is not sufficient to significantly raise the fast hemoglobin levels. These results are in agreement with those of a recent study (Dods and Bolmey, 1979) in which it was concluded that fast hemoglobin measurements are consistent with a conservative approach to the diagnosis of diabetes. The results are also consistent with the idea that the observed glucose intolerance in a number of these subjects may be due to their inability to utilize a glucose load at a normal rate (due to their low muscle mass), but they do not exhibit a sustained hyperglycemia.
No increase in glycosylated hemoglobins was found for the siblings, while the slight increase in the total fast Hb in the heterozygotes (as determined by Method 1) parallels a slight (but not significant) increase in blood glucose levels which may in part represent a natural trend with increasing age. The increase in HbA IC for this group was not significant. As mentioned previously, the apparent difference between the two methods may be partly explained by the fact that only 4 subjects were subjected to both analytical methods.
In summary, we have measured glycosylated hemoglobins in Friedreich's Ataxia patients and in family members to determine whether the measurement of fast hemoglobins provides a more sensitive index of glucose intolerance than plasma glucose determinations. It is concluded that in Friedreich's ataxia patients and family members (apart from the insulin dependent diabetics), there was no hyperglycemia sufficient to be detected as an increase in glycosylated hemoglobins. This approach can be recommended as part of the protocol in the long term monitoring of the control of diabetes in Friedreich's ataxia.
